Insider · CIK 0001626850
Allan Shaw
Files at CALC (CalciMedica, Inc.). First filing -, latest -.
Allan Shaw files SEC Form 4 as director at CALC (CalciMedica, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Allan Shaw has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | 8 d ago |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jun 26, 2025 |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +8,594 | $0.00 | $0 | 8,594 | Jun 26, 2025 |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +26,250 | $0.00 | $0 | 26,250 | Jun 26, 2025 |
| Jun 24, 2025 | CALC CalciMedica, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jun 26, 2025 |
Questions about Allan Shaw
Answered from the filings on this page, as of the latest one.
Is Allan Shaw buying or selling?
Allan Shaw has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Allan Shaw's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Allan Shaw has 0.
Where does Allan Shaw file Form 4?
Allan Shaw has filed Form 4 at CALC (CalciMedica, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.